We describe how to perform retroviral or lentiviral infections of overexpression or shRNA-containing constructs in the human Ramos B-cell line and how to measure somatic hypermutation in these cells.
B cells start their life with low affinity antibodies generated by V(D)J recombination. However, upon detecting a pathogen, the variable (V) region of an immunoglobulin (Ig) gene is mutated approximately 100,000-fold more than the rest of the genome through somatic hypermutation (SHM), resulting in high affinity antibodies1,2. In addition, class switch recombination (CSR) produces antibodies with different effector functions depending on the kind of immune response that is needed for a particular pathogen. Both CSR and SHM are initiated by activation-induced cytidine deaminase (AID), which deaminates cytosine residues in DNA to produce uracils. These uracils are processed by error-prone forms of repair pathways, eventually leading to mutations and recombination1-3.
Our current understanding of the molecular details of SHM and CSR come from a combination of studies in mice, primary cells, cell lines, and cell-free experiments. Mouse models remain the gold standard with genetic knockouts showing critical roles for many repair factors (e.g. Ung, Msh2, Msh6, Exo1, and polymerase η)4-10. However, not all genes are amenable for knockout studies. For example, knockouts of several double-strand break repair proteins are embryonically lethal or impair B-cell development11-14. Moreover, sometimes the specific function of a protein in SHM or CSR may be masked by more global defects caused by the knockout. In addition, since experiments in mice can be lengthy, altering expression of individual genes in cell lines has become an increasingly popular first step to identifying and characterizing candidate genes15-18.
Ramos – a Burkitt lymphoma cell line that constitutively undergoes SHM – has been a popular cell-line model to study SHM18-24. One advantage of Ramos cells is that they have a built-in convenient semi-quantitative measure of SHM. Wild type cells express IgM and, as they pick up mutations, some of the mutations knock out IgM expression. Therefore, assaying IgM loss by fluorescence-activated cell scanning (FACS) provides a quick read-out for the level of SHM. A more quantitative measurement of SHM can be obtained by directly sequencing the antibody genes.
Since Ramos cells are difficult to transfect, we produce stable derivatives that have increased or lowered expression of an individual gene by infecting cells with retroviral or lentiviral constructs that contain either an overexpression cassette or a short hairpin RNA (shRNA), respectively. Here, we describe how we infect Ramos cells and then use these cells to investigate the role of specific genes on SHM (Figure 1).
1. Preparing samples and cells
2. Transfecting BOSC 23 cells
3. Harvesting viral particles
4. Infecting B cells
5. Single cell seeding
Single seeding can be performed in one of two ways: by FACS sorting or manually.
6. Analysis: IgM loss (3 weeks and 5 weeks)
7. Analysis: Confirm knock-down by quantitative RT-PCR (5 weeks)
8. Analysis: Genomic sequencing (5 weeks)
9. Representative Results:
As noted before, we use a positive control viral vector that expresses both GFP as well as a puromycin-resistance gene. We typically see 50-75% GFP+ cells two days after transfection. In our infections, we typically see 50-70% cells are GFP+ two days after infection but before selection. After selection is complete, >95% of cells are GFP+.
As representative experiments, we show the effects of overexpressing AID or knocking down a repair factor in Ramos cells. Specifically, we transfected a retroviral overexpression vector for AID linked via an IRES site to Thy1.1 along with the retroviral packaging vector pKat2 into BOSC 23 cells. Virus-containing media was filtered and then used to infect Ramos cells. Both wild type (WT) and AID overexpressing (AIDhi) cells were single cell seeded and grown for 3 weeks, at which point they were analyzed for gene expression by qRT-PCR (Figure 2) and for IgM loss by FACS (Figure 3). For the FACS staining, the cells were incubated with both 1:20 diluted PE-labeled α-human IgM antibody as well as 1:400 diluted FITC-labeled α-rat CD90/mouse CD90.1 (Thy1.1) antibody. In a separate experiment, lentiviruses containing either an irrelevant shRNA (control) or an shRNA against a high-fidelity DNA repair factor expected to protect against SHM were made in BOSC 23 cells, and then infected into an AIDhi clone of Ramos cells. Again, gene expression (Figure 4) and IgM loss (Figure 5) were analyzed in single cell clones after 3 weeks. Since the repair factor is thought to provide protection against mutations during SHM, we see an increase in IgM loss and SHM in the absence of the factor. If we had knocked-down a factor involved in generating SHM-associated mutations, we would have seen a decrease in IgM loss instead.
As expected, our qRT-PCR results show a marked increase in AID expression following infection of cells with an AID overexpression vector (Figure 2), while levels of the DNA repair factor drop in the presence of a targeted shRNA against that factor (Figure 4). Because individual clones may vary, you might see some variation in gene expression levels. Because gene expression can vary, it is necessary to confirm the expression in each clone you plan on analyzing further. Different shRNAs against the same gene might have different effects on gene expression as well, so you should screen several shRNAs to determine which has the greatest impact. Knockdown may also be confirmed at the protein level by immunoblotting. Likewise, individual clones might vary greatly in levels of IgM loss. Some clones might demonstrate a “jackpot” effect, where an IgM mutation occurred in one of the earliest cell divisions – for example, you will see >50% IgM loss simply because one of the cells became IgM– at the two-cell stage. The influence of these clones is minimized by calculating the median for several single cell clones.
Figure 1. Schematic for the transfection, infection and analysis of IgM loss. See text for details.
Figure 2. AID overexpression in Ramos cells. WT and AIDhi Ramos cells were single cell cloned and grown for 3 weeks, at which point AID expression in individual clones was measured by qRT-PCR. GAPDH expression was used for normalization. WT was set to 1. The median value is indicated. * indicates a p value of <0.01, calculated as a one-tailed Student′s t-test.
Figure 3. Increased IgM loss in AIDhi cells as compared to WT cells. Surface IgM was measured by FACS at the 3 week time point, and the percentage of IgM loss was calculated for WT and AIDhi cells. (A) Representative FACS plot of a WT clone and an AIDhi clone. The AID overexpression vector has AID linked to Thy1.1 via an IRES site, so Thy1.1 expression is used as a surrogate for AID expression. (B) Quantitation of IgM loss in several WT and AIDhi clones. The median value is indicated. * indicates a p value of <0.01, calculated as a one-tailed Student’s t-test.
Figure 4. Knockdown of a repair factor in AIDhi cells. Cells were infected with either an irrelevant shRNA control (control) or our shRNA of interest (shRNA), and single cell seeded. After 3 weeks, gene expression in individual clones was measured by qRT-PCR. GAPDH expression was used for normalization. WT was set to 1. The median value is indicated. * indicates a p value of <0.01, calculated as a one-tailed Student’s t-test.
Figure 5. Increased IgM loss in AIDhi cells with knocked-down levels of a repair factor. Surface IgM in several clones was measured by FACS at the 3 week time point, and the percentage of IgM loss was calculated in cells still overexpressing AID. The median value is indicated. * indicates a p value of <0.01, calculated as a one-tailed Student′s t-test.
Table 1. Primer sequences for the Ig genes19: the constant region Cμ, the heavy chain V region (VH), and the light chain V region (VL).
As discussed previously, cell line models for antibody diversification have become a popular starting point to identify novel proteins that influence different steps during antibody diversification. We present here a method for using viral infection to either knock-down or overexpress proteins in the Ramos B-cell line and then examine the impact on SHM.
For these studies, we utilize both WT Ramos and AIDhi Ramos cells. WT cells can be used to study factors involved in targeting or expression of AID as well as repair of AID-generated lesions, while AIDhi cells exclude factors that affect AID expression.
It should also be noted that, SHM is measured here by assaying for loss of IgM from a population of cells that are initially IgM+. Alternatively, it is possible to start with IgM– cells and look for a gain of IgM+ cells in a reversion assay23.
By using different selection markers (e.g. puromycin, hygromycin, GFP, or Thy1.1), we can also perform multiple infections at the same time with the same protocol. However, we have found that when using two different antibiotic selection markers, the sensitivities of the cells change. It will be necessary to perform additional kill curves to optimize the conditions for selecting with two antibiotics at once. We can easily generate double knock-downs of two different factors or a knock-down of one factor plus an overexpression of another, etc.
We have also adapted this protocol for other B-cell-line models as well. For instance, with CH12F3-2 cells (a mouse B-cell line used to study CSR) 26,27, the same infection steps can be used to infect 1 x 106 CH12F3-2 cells seeded on the day of infection (variation of step 4.1). These cells are selected with 1 μg/mL of puromycin. Similarly, the same protocol can also be used for chicken DT40 cells – a cell line model for AID-initiated gene conversion.
The authors have nothing to disclose.
The pMSCV-AID-I-Thy1.1 and pKat2 vectors were a kind gift from D. G. Schatz and the pVSV-G, pRSV-Rev, and pMDLg/pRRE vectors were a kind gift from B. R. Cullen.
Suggested reagents – most of these may be substituted with similar products from other vendors.
Name of the reagent | Company | Catalogue number | Comments |
---|---|---|---|
6-well clear TC-treated plates | Corning | 3516 | |
10 mL BD Luer-Loksyringes | BD Medical | 309604 | |
24-well clear TC-treated plates | Corning | 3526 | |
96-well clear flat bottom polystyrene TC-treated microplates | Corning | 3596 | |
100 mm TC-treated culture dishes | Corning | 430167 | |
Acrodisc syringe filters, 0.45 μm | Pall Life Sciences | 4604 | |
Agar | Teknova | A7777 | |
Agarose | GeneMate | E-3120-500 | |
Ampicillin | Sigma | A0166 | 100 mg/mL in water |
BD FACSCanto II flow cytometer | BD Biosciences | or similar | |
BD Falcon round bottom polystyrene tubes | BD Biosciences | 352054 | for FACS |
BOSC 23 cells | ATCC | CRL-11270 | |
CO2 incubator capable of 37°C | |||
DMEM (Dulbecco′s modified Eagle′s medium) | Sigma | D6429 | |
FBS (fetal bovine serum) | Gemini Bio-Products | 100-106 | |
FITC α-rat CD90/mouse CD90.1 antibody | BioLegend | 202503 | FITC α-Thy1.1 |
FuGENE 6 Transfection Reagent | Roche | 11814443001 | |
HEPES buffer solution | Invitrogen | 15630-080 | |
KAPA HiFi DNA polymerase | KAPA Biosystems | KK2101 | |
LB Broth (lysogeny broth – Luria) Powder | Difco | 240230 | |
MISSION TRC shRNA bacterial glycerol stock | Sigma | shRNA vectors | |
NCS (newborn calf serum) | Gemini Bio-Products | 100-504 | |
PBS (phosphate buffered solution) | Invitrogen | 70011 | diluted to 1x in water |
PE α-human IgM antibody | BioLegend | 314508 | |
PGS (penicillin-streptomycin-glutamine solution) | Gemini Bio-Products | 400-110 | |
Polybrene (hexadimethrine bromide) | Sigma | 107689 | 10 mg/mL in water |
PureYield Plasmid Midiprep System | Promega | A2495 | |
Puromycin | Sigma | P8833 | 250 μg/mL in water |
QIAquick gel extraction kit | QIAGEN | 28706 | |
Ramos (RA 1) cells | ATCC | CRL-1596 | |
RPMI-1640 medium | Sigma | R8758 | |
SuperScript II | Invitrogen | 18064-022 | |
SYBR FAST qPCR kit | KAPA Biosystems | KK4601 | |
Taq DNA Polymerase | Invitrogen | 18038-042 | |
TOPO TA Cloning kit | Invitrogen | K4520-01 | |
TRIzol | Invitrogen | 15596-026 | |
Wizard SV Genomic DNA purification system | Promega | A2361 | |
X-Gal [5-bromo-4-chloro-3-indoyl-β-D-galatopyranoside] | Growcells | C-5687 | 40 mg/mL in DMSO |